Skip to main content

Advertisement

SpringerLink
Log in

Multiple Sclerosis and Reproductive Risks in Women

  • Review Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

During the previous decades, women with Multiple Sclerosis (MS) were discouraged from having children, as pregnancy was deemed dangerous for pregnancy outcome and a contributing factor for exacerbation of MS. Current knowledge shows that women with MS are no more likely to have pregnancy or delivery complications compared to healthy women. Immunomodulatory therapies should be avoided during pregnancy and while breastfeeding. However, despite that it is still not recommended during pregnancy, Glatiramer acetate has fewer risks than the other MS drugs with respect to pregnancy outcome. IVIg treatment appears to be safe in unblinded studies and may be used after the first trimester to prevent the exacerbation of postpartum relapses. Gestation is a period of decreased risk for a relapse, whereas relapses are more common in the first six months after childbirth, compared to the pre-pregnancy period. Breastfeeding and epidural anaesthesia are not associated with increased incidence of post-partum relapses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benedict RH, Bobholz JH Multiple sclerosis. Semin Neurol. 2007;27:78–85.

    Article  PubMed  Google Scholar 

  2. Ness JM, Chabas D., Sadovnick AD, Pohl D., Banwell B., Weinstock-Guttman B. for the International Pediatric MS Study Group. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007;68(16 suppl 2):S37–S45.

    Article  CAS  PubMed  Google Scholar 

  3. Desousa EA, Albert RH, Kalman B. Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen. 2002;17(1):23–29.

    Article  PubMed  Google Scholar 

  4. Polman CH, Reingold SC, Edan G., Filippi M., Hartung HP, Kappos L., Lublin FD, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58:840–846.

    Article  PubMed  Google Scholar 

  5. Vollmer T. The natural history of relapses in multiple sclerosis. J Neurol Sci. 2007;256(suppl 1):S5–S13.

    Article  PubMed  Google Scholar 

  6. Bennett KA Pregnancy and multiple sclerosis. Clin Obstet Gynecol. 2005;48:38–47.

    Article  PubMed  Google Scholar 

  7. Whitaker JN Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med. 1998;339:339–340.

    Article  CAS  PubMed  Google Scholar 

  8. Mueller BA, Zhang J., Critchlow CW Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol. 2002;186:446–452.

    Article  PubMed  Google Scholar 

  9. Oksenberg JR, Barcellos LF The complex genetic aetiology of multiple sclerosis. J Neurovirol. 2000;6(suppl 2):S10–S14.

    CAS  PubMed  Google Scholar 

  10. Kantarci O., Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol. 2006;19:248–254.

    Article  PubMed  Google Scholar 

  11. Weber F., Fontaine B., Cournu-Rebeix I., et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun. 2008;9: 259–263.

    Article  CAS  PubMed  Google Scholar 

  12. Dyment DA, Ebers GC, Sadovnick AD Genetics of multiple sclerosis. Lancet Neurol. 2004;3:104–110.

    Article  CAS  PubMed  Google Scholar 

  13. Ferrero S., Pretta S., Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004;115:3–9.

    Article  PubMed  Google Scholar 

  14. Orvieto R., Achiron R., Rotstein Z., Noy S., Bar-Hava I., Achiron A. Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol. 1999;82:191–194.

    Article  CAS  PubMed  Google Scholar 

  15. Worthington J., Jones R., Crawford M., Forti A. Pregnancy and multiple sclerosis-a 3-year prospective study. J Neurol. 1994;241:228–233.

    Article  CAS  PubMed  Google Scholar 

  16. Dahl J., Myhr KM, Daltveit AK, Gilhus NE Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol. 2008;255:623–627.

    Article  PubMed  Google Scholar 

  17. Sadovnick AD, Eisen K., Hashimoto SA, et al. Pregnancy and multiple sclerosis. A prospective study. Arch Neurol. 1994;51: 1120–1124.

    Article  CAS  PubMed  Google Scholar 

  18. De Las Heras V., De Andrés C., Téllez N., Tintoré M. for the EMPATIE Study Group. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler. 2007;13:981–984.

    Article  PubMed  Google Scholar 

  19. Durufle A., Nicolas B., Petrilli S., et al. Effects of pregnancy and childbirth on the incidence of urinary disorders in multiple sclerosis. Clin Exp Obstet Gynecol. 2006;33: 215–218.

    CAS  PubMed  Google Scholar 

  20. Webb JA, Thomsen HS, Morcos SK The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234–1240. for the Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR).

    Article  PubMed  Google Scholar 

  21. Paavilainen T., Kurki T., Parkkola R., et al. Magnetic resonance imaging of the brain used to detect early postpartum activation of multiple sclerosis. Eur J Neurol. 2007;14:1216–1221.

    Article  CAS  PubMed  Google Scholar 

  22. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Guidelines for diagnostic imaging during pregnancy. ACOG Committee Opinion No. 158. Washington, DC: ACOG; 1995.

  23. Bernardi S., Grasso MG, Bertollini R., Orzi F., Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand. 1991;84:403–406.

    Article  CAS  PubMed  Google Scholar 

  24. Confavreux C., Hutchinson M., Hours M., et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998;339:285–291.

    Article  CAS  PubMed  Google Scholar 

  25. Saraste M., Väisänen S., Alanen A., Airas L., and the Finnish multiple Sclerosis and Pregnancy Study Group. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med. 2007;4:45–55.

    Article  PubMed  Google Scholar 

  26. Airas L., Saraste M., Rinta S., Elovaara I., Huang YH, Wiendl H., and the Finnish multiple Sclerosis and Pregnancy Study Group. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol. 2008;151:235–243.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Doria A., Iaccarino L., Arienti S., et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006;22:234–241.

    Article  CAS  PubMed  Google Scholar 

  28. Al-Shammri S., Rawoot P., Azizieh F., et al. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci. 2004;222:21–27.

    Article  CAS  PubMed  Google Scholar 

  29. Zhu WH, Lu CZ, Huang YM, Link H., Xiao BG A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult Scler. 2007;13:33–40.

    Article  CAS  PubMed  Google Scholar 

  30. Gregg C., Shikar V., Larsen P., et al. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci. 2007;27:1812–1823.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Voskuhl RR Hormone-based therapies in MS. Int MS J. 2003;10:60–66.

    CAS  PubMed  Google Scholar 

  32. Guthrie TC, Nelson DA Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci. 1995;129:1–8.

    Article  CAS  PubMed  Google Scholar 

  33. Bader AM, Hunt CO, Datta S., et al. Anesthesia for obstetric patients with multiple sclerosis. J Clin Anesth. 1988;1:21–24.

    Article  CAS  PubMed  Google Scholar 

  34. Dorotta IR, Schubert A. Multiple sclerosis and anesthetic implications. Curr Opin. Anaesthesiol. #2002;15:365–370.

    Google Scholar 

  35. Crawford JS Epidural analgesia for patients with chronic neurological disease. Anesth Analg. 1983;62:621–622.

    Article  CAS  PubMed  Google Scholar 

  36. Capdeville M., Hoyt MR Anesthesia and analgesia in the obstetric population with multiple sclerosis. A retrospective review. Anesthesiology. 1994;81:1173.

    Article  Google Scholar 

  37. Jones RM, Healy TE Anesthesia and demyelinating disease. Anaesthesia. 1980;35:879–884.

    Article  CAS  PubMed  Google Scholar 

  38. Vercauteren M., Heytens L. Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe? Acta Anaesthesiol. Scand. 2007;51:831–838.

    Article  CAS  PubMed  Google Scholar 

  39. Cooperman LH Succinylcholine induced hyperkalemia in neuromuscular disease. JAMA. 1970;213:1867–1871.

    Article  CAS  PubMed  Google Scholar 

  40. Drake E., Drake M., Bird J., Russell R. Obstetric regional blocks for women with multiple sclerosis: a survey of UK experience. Int J Obstet Anesth. 2006;15:115–123.

    Article  CAS  PubMed  Google Scholar 

  41. Rayburn WF Glucocorticoid therapy for rheumatic diseases: maternal, fetal, and breast-feeding considerations. Am J Reprod Immunol. 1992;28:138–140.

    Article  CAS  PubMed  Google Scholar 

  42. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–789.

    Article  Google Scholar 

  43. Nguyen C., Duhl AJ, Escallon CS, Blakemore KJ Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol. 2002;99:599–602.

    CAS  PubMed  Google Scholar 

  44. Bar Oz B., Hackman R., Einarson T., Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71:1051–1055.

    Article  CAS  PubMed  Google Scholar 

  45. De Santis M., Straface G., Cavaliere AF, Rosati P., Batocchi AP, Caruso A. The first case of mitoxantrone exposure in early pregnancy. Neurotoxicology. 2007;28:696–697.

    Article  PubMed  CAS  Google Scholar 

  46. Ostensen M. Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation. Am J Reprod Immunol. 1992;28:148–152.

    Article  CAS  PubMed  Google Scholar 

  47. Avonex (Interferon beta 1-a). Biogen, Canada, 1998. Product monograph.

  48. Boskovic R., Wide R., Wolpin J., Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology. 2005;65:807–811.

    Article  CAS  PubMed  Google Scholar 

  49. Sandberg-Wollheim M., Frank D., Goodwin TM, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 2005;65:802–806.

    Article  CAS  PubMed  Google Scholar 

  50. Achiron A., Kishner I., Dolev M., et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol. 2004;251: 1133–1137.

    Article  CAS  PubMed  Google Scholar 

  51. Nelson LM, Franklin GM, Jones MC Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA. 1988;259:3441–3443.

    Article  CAS  PubMed  Google Scholar 

  52. Vukusic S., Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg. 2006;108: 266–270.

    Article  PubMed  Google Scholar 

  53. Vukusic S., Hutchinson M., Hours M., et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004;127:1353–1360.

    Article  PubMed  Google Scholar 

  54. Roullet E., Verdier-Taillefer MH, Amarenco P., Gharbi G., Alperovitch A., Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry. 1993;56:1062–1065.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Hellwig K., Brune N., Haghikia A., et al. Reproductive counselling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand. 2008;118:24–28.

    Article  CAS  PubMed  Google Scholar 

  56. De Seze J., Chapelotte M., Delalande S., Ferriby D., Stojkovic T., Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler. 2004;10:596–597.

    Article  PubMed  Google Scholar 

  57. El-Etr M., Vukusic S., Gignoux L., et al. Steroid hormones in multiple sclerosis. J Neurol Sci. 2005;233:49–54.

    Article  CAS  PubMed  Google Scholar 

  58. Antonio M., Patrizia F., Ilaria I., Paolo F. A rational approach on the use of sex steroids in multiple sclerosis. Recent Patents CNS Drug Discov. 2008;3:34–39.

    Article  CAS  Google Scholar 

  59. Palaszynski KM, Liu H., Loo KK, Voskuhl RR Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol. 2004;149:84–89.

    Article  CAS  PubMed  Google Scholar 

  60. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452.

    Article  CAS  PubMed  Google Scholar 

  61. Weinshenker BG, Hader W., Carriere W., Baskerville J., Ebers GC The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology. 1989;39:1438–1440.

    Article  CAS  PubMed  Google Scholar 

  62. Runmarker B., Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain. 1995;118:253–261.

    Article  PubMed  Google Scholar 

  63. Verdru P., Theys P., D’Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg. 1994;96:38–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Saint Andrew’s General Hospital of Patras, 26335, Patras, Greece

    Andreas A. Argyriou MD, PhD & Nicolaos Makris MD, PhD

Authors
  1. Andreas A. Argyriou MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolaos Makris MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas A. Argyriou MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Argyriou, A.A., Makris, N. Multiple Sclerosis and Reproductive Risks in Women. Reprod. Sci. 15, 755–764 (2008). https://doi.org/10.1177/1933719108324138

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719108324138

Key words

Search

Navigation